Impact factor mania and publish-or-perish may have contributed to Dana-Farber retractions, experts sayLearning from past errors (and misconduct) in cancer research February 02, 2024Vol.50 No.05By Jacquelyn Cobb
Regulatory News FDA tells sponsors of CAR T-cell therapies to add boxed warning about secondary T-cell malignancies February 02, 2024Vol.50 No.05By Alexandria Carolan
Black History Month Video series uses storytelling to increase diversity in clinical trials: “Having a seat at the table is essential” February 02, 2024Vol.50 No.05
NCI Outstanding Investigator Award (with up to $600,000 a year) goes to 17 scientists February 02, 2024Vol.50 No.05By Jacquelyn Cobb
In Brief C. Norman Coleman receives Henderson Lifetime Achievement Award February 02, 2024Vol.50 No.05
In Brief David Pfister to step down as chief of the Head and Neck Oncology Service at MSK February 02, 2024Vol.50 No.05
In Brief Pamela Kunz named editor-in-chief of new JCO Oncology Advances February 02, 2024Vol.50 No.05
In Brief Michael Lotze named editor-in-chief of SITC’s Journal for ImmunoTherapy of Cancer February 02, 2024Vol.50 No.05
In Brief MD Anderson designated IAEA Collaborating Centre to focus on improving radiation, radiology and nuclear medicine February 02, 2024Vol.50 No.05
